1 Study Coverage 1.1 Pemphigus Vulgaris Treatment Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Introduction 1.2 Global Pemphigus Vulgaris Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Pemphigus Vulgaris Treatment Market Size for the Year 2017-2028 1.2.2 Global Pemphigus Vulgaris Treatment Market Size for the Year 2017-2028 1.3 Pemphigus Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Pemphigus Vulgaris Treatment in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Pemphigus Vulgaris Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Pemphigus Vulgaris Treatment Market Dynamics 1.4.1 Pemphigus Vulgaris Treatment Industry Trends 1.4.2 Pemphigus Vulgaris Treatment Market Drivers 1.4.3 Pemphigus Vulgaris Treatment Market Challenges 1.4.4 Pemphigus Vulgaris Treatment Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Pemphigus Vulgaris Treatment by Type 2.1 Pemphigus Vulgaris Treatment Market Segment by Type 2.1.1 Oral 2.1.2 Injectable 2.2 Global Pemphigus Vulgaris Treatment Market Size by Type (2017, 2022 & 2028) 2.3 Global Pemphigus Vulgaris Treatment Market Size by Type (2017-2028) 2.4 United States Pemphigus Vulgaris Treatment Market Size by Type (2017, 2022 & 2028) 2.5 United States Pemphigus Vulgaris Treatment Market Size by Type (2017-2028) 3 Pemphigus Vulgaris Treatment by Application 3.1 Pemphigus Vulgaris Treatment Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.2 Global Pemphigus Vulgaris Treatment Market Size by Application (2017, 2022 & 2028) 3.3 Global Pemphigus Vulgaris Treatment Market Size by Application (2017-2028) 3.4 United States Pemphigus Vulgaris Treatment Market Size by Application (2017, 2022 & 2028) 3.5 United States Pemphigus Vulgaris Treatment Market Size by Application (2017-2028) 4 Global Pemphigus Vulgaris Treatment Competitor Landscape by Company 4.1 Global Pemphigus Vulgaris Treatment Market Size by Company 4.1.1 Top Global Pemphigus Vulgaris Treatment Companies Ranked by Revenue (2021) 4.1.2 Global Pemphigus Vulgaris Treatment Revenue by Player (2017-2022) 4.2 Global Pemphigus Vulgaris Treatment Concentration Ratio (CR) 4.2.1 Pemphigus Vulgaris Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Pemphigus Vulgaris Treatment in 2021 4.2.3 Global Pemphigus Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Pemphigus Vulgaris Treatment Headquarters, Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Type 4.3.1 Global Pemphigus Vulgaris Treatment Headquarters and Area Served 4.3.2 Global Pemphigus Vulgaris Treatment Companies Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Pemphigus Vulgaris Treatment Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Pemphigus Vulgaris Treatment Market Size by Company 4.5.1 Top Pemphigus Vulgaris Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Pemphigus Vulgaris Treatment Revenue by Players (2020, 2021 & 2022) 5 Global Pemphigus Vulgaris Treatment Market Size by Region 5.1 Global Pemphigus Vulgaris Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Pemphigus Vulgaris Treatment Market Size by Region (2017-2028) 5.2.1 Global Pemphigus Vulgaris Treatment Market Size by Region: 2017-2022 5.2.2 Global Pemphigus Vulgaris Treatment Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Pemphigus Vulgaris Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Pemphigus Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Pemphigus Vulgaris Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Pemphigus Vulgaris Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Pemphigus Vulgaris Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Pemphigus Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Pemphigus Vulgaris Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Pemphigus Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Pemphigus Vulgaris Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Pemphigus Vulgaris Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Roche 7.1.1 Roche Company Details 7.1.2 Roche Business Overview 7.1.3 Roche Pemphigus Vulgaris Treatment Introduction 7.1.4 Roche Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.1.5 Roche Recent Development 7.2 Novartis 7.2.1 Novartis Company Details 7.2.2 Novartis Business Overview 7.2.3 Novartis Pemphigus Vulgaris Treatment Introduction 7.2.4 Novartis Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.2.5 Novartis Recent Development 7.3 GlaxoSmithKline 7.3.1 GlaxoSmithKline Company Details 7.3.2 GlaxoSmithKline Business Overview 7.3.3 GlaxoSmithKline Pemphigus Vulgaris Treatment Introduction 7.3.4 GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.3.5 GlaxoSmithKline Recent Development 7.4 Mylan 7.4.1 Mylan Company Details 7.4.2 Mylan Business Overview 7.4.3 Mylan Pemphigus Vulgaris Treatment Introduction 7.4.4 Mylan Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.4.5 Mylan Recent Development 7.5 Genentech 7.5.1 Genentech Company Details 7.5.2 Genentech Business Overview 7.5.3 Genentech Pemphigus Vulgaris Treatment Introduction 7.5.4 Genentech Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.5.5 Genentech Recent Development 7.6 Principia Biopharma 7.6.1 Principia Biopharma Company Details 7.6.2 Principia Biopharma Business Overview 7.6.3 Principia Biopharma Pemphigus Vulgaris Treatment Introduction 7.6.4 Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.6.5 Principia Biopharma Recent Development 7.7 Argenx 7.7.1 Argenx Company Details 7.7.2 Argenx Business Overview 7.7.3 Argenx Pemphigus Vulgaris Treatment Introduction 7.7.4 Argenx Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.7.5 Argenx Recent Development 7.8 Alexion 7.8.1 Alexion Company Details 7.8.2 Alexion Business Overview 7.8.3 Alexion Pemphigus Vulgaris Treatment Introduction 7.8.4 Alexion Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.8.5 Alexion Recent Development 7.9 Vifor Pharma 7.9.1 Vifor Pharma Company Details 7.9.2 Vifor Pharma Business Overview 7.9.3 Vifor Pharma Pemphigus Vulgaris Treatment Introduction 7.9.4 Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) 7.9.5 Vifor Pharma Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Pemphigus Vulgaris Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Pemphigus Vulgaris Treatment Market Trends Table 3. Pemphigus Vulgaris Treatment Market Drivers Table 4. Pemphigus Vulgaris Treatment Market Challenges Table 5. Pemphigus Vulgaris Treatment Market Restraints Table 6. Global Pemphigus Vulgaris Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Pemphigus Vulgaris Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Pemphigus Vulgaris Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Pemphigus Vulgaris Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Pemphigus Vulgaris Treatment Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Pemphigus Vulgaris Treatment Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Pemphigus Vulgaris Treatment Revenue Share by Player, 2017-2022 Table 13. Global Pemphigus Vulgaris Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Pemphigus Vulgaris Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemphigus Vulgaris Treatment as of 2021) Table 15. Top Players of Pemphigus Vulgaris Treatment in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Pemphigus Vulgaris Treatment Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Pemphigus Vulgaris Treatment Players in United States Market, Ranking by Revenue (2021) Table 20. United States Pemphigus Vulgaris Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Pemphigus Vulgaris Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Pemphigus Vulgaris Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Pemphigus Vulgaris Treatment Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Pemphigus Vulgaris Treatment Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Pemphigus Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Pemphigus Vulgaris Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Pemphigus Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Pemphigus Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Pemphigus Vulgaris Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Roche Company Details Table 31. Roche Business Overview Table 32. Roche Pemphigus Vulgaris Treatment Product Table 33. Roche Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 34. Roche Recent Development Table 35. Novartis Company Details Table 36. Novartis Business Overview Table 37. Novartis Pemphigus Vulgaris Treatment Product Table 38. Novartis Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 39. Novartis Recent Development Table 40. GlaxoSmithKline Company Details Table 41. GlaxoSmithKline Business Overview Table 42. GlaxoSmithKline Pemphigus Vulgaris Treatment Product Table 43. GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 44. GlaxoSmithKline Recent Development Table 45. Mylan Company Details Table 46. Mylan Business Overview Table 47. Mylan Pemphigus Vulgaris Treatment Product Table 48. Mylan Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 49. Mylan Recent Development Table 50. Genentech Company Details Table 51. Genentech Business Overview Table 52. Genentech Pemphigus Vulgaris Treatment Product Table 53. Genentech Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 54. Genentech Recent Development Table 55. Principia Biopharma Company Details Table 56. Principia Biopharma Business Overview Table 57. Principia Biopharma Pemphigus Vulgaris Treatment Product Table 58. Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 59. Principia Biopharma Recent Development Table 60. Argenx Company Details Table 61. Argenx Business Overview Table 62. Argenx Pemphigus Vulgaris Treatment Product Table 63. Argenx Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 64. Argenx Recent Development Table 65. Alexion Company Details Table 66. Alexion Business Overview Table 67. Alexion Pemphigus Vulgaris Treatment Product Table 68. Alexion Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 69. Alexion Recent Development Table 70. Vifor Pharma Company Details Table 71. Vifor Pharma Business Overview Table 72. Vifor Pharma Pemphigus Vulgaris Treatment Product Table 73. Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2017-2022) & (US$ Million) Table 74. Vifor Pharma Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Pemphigus Vulgaris Treatment Product Picture Figure 2. Global Pemphigus Vulgaris Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Pemphigus Vulgaris Treatment Market Size 2017-2028 (US$ Million) Figure 4. United States Pemphigus Vulgaris Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Pemphigus Vulgaris Treatment Market Size 2017-2028 (US$ Million) Figure 6. United States Pemphigus Vulgaris Treatment Market Share in Global 2017-2028 Figure 7. Pemphigus Vulgaris Treatment Report Years Considered Figure 8. Product Picture of Oral Figure 9. Product Picture of Injectable Figure 10. Global Pemphigus Vulgaris Treatment Market Share by Type in 2022 & 2028 Figure 11. Global Pemphigus Vulgaris Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Pemphigus Vulgaris Treatment Market Share by Type (2017-2028) Figure 13. United States Pemphigus Vulgaris Treatment Market Share by Type in 2022 & 2028 Figure 14. United States Pemphigus Vulgaris Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Pemphigus Vulgaris Treatment Market Share by Type (2017-2028) Figure 16. Product Picture of Hospital Pharmacies Figure 17. Product Picture of Retail Pharmacies Figure 18. Product Picture of Online Pharmacies Figure 19. Global Pemphigus Vulgaris Treatment Market Share by Application in 2022 & 2028 Figure 20. Global Pemphigus Vulgaris Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Pemphigus Vulgaris Treatment Market Share by Application (2017-2028) Figure 22. United States Pemphigus Vulgaris Treatment Market Share by Application in 2022 & 2028 Figure 23. United States Pemphigus Vulgaris Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Pemphigus Vulgaris Treatment Market Share by Application (2017-2028) Figure 25. North America Pemphigus Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Pemphigus Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Pemphigus Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Pemphigus Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Pemphigus Vulgaris Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Pemphigus Vulgaris Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Roche Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 54. Novartis Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 55. GlaxoSmithKline Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 56. Mylan Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 57. Genentech Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 58. Principia Biopharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 59. Argenx Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 60. Alexion Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 61. Vifor Pharma Revenue Growth Rate in Pemphigus Vulgaris Treatment Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Roche Novartis GlaxoSmithKline Mylan Genentech Principia Biopharma Argenx Alexion Vifor Pharma